Delivery Order SPE2DB22D3301-SPE2DB25FZ1NA
- Not listed
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,762.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 29, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $5,563.36. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $32,034.58 on May 12, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,352.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 25, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This contract represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $27,419.98 and an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $15,723.83 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The delivery will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,120.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was awarded on a competitive basis with no set-aside designation. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, valued at $6,546.24, represents a firm fixed price delivery order with an ultimate completion date of June 17, 2025. The award was made on a competitive, non-set-aside basis and is performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1NADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) valued at $8,457.03. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. As a child contract under a larger vehicle, this delivery order draws from AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply program for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare programs. The company maintains an extensive portfolio of pharmaceutical products and medical supplies through its DLA prime contract, which encompasses brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This specific delivery order for DESCOVY, an HIV treatment medication, reflects the company's role in supplying specialized pharmaceutical products to support military and federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/25/25 |